Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
about
Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology."Neurological complications of new chemotherapy agents".Absolute Bioavailability of Bosutinib in Healthy Subjects From an Open-Label, Randomized, 2-Period Crossover Study.Bosutinib in chronic myeloid leukemia: patient selection and perspectives.Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
P2860
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
@en
type
label
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
@en
prefLabel
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
@en
P2860
P1476
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
@en
P2093
Poe-Hirr Hsyu
Richat Abbas
P2860
P2888
P304
P356
10.1007/S40262-016-0391-6
P577
2016-04-25T00:00:00Z
P6179
1021502385